Report Update Nov 1, 2024

China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

China: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in China

In 2021, the Chinese medicaments containing insulin market decreased by -4.6% to $X, falling for the third year in a row after three years of growth. Overall, consumption showed a sharp shrinkage. Over the period under review, the market reached the maximum level at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in China

In value terms, medicaments containing insulin production fell slightly to $X in 2021 estimated in export price. In general, production, however, saw a relatively flat trend pattern. The growth pace was the most rapid in 2018 when the production volume increased by 3.9% against the previous year. Over the period under review, production attained the peak level at $X in 2020, and then reduced modestly in the following year.

Medicaments Containing Insulin Exports

Exports from China

For the seventh consecutive year, China recorded decline in overseas shipments of medicaments containing insulin but not antibiotics, which decreased by -53.4% to X kg in 2021. Overall, exports showed a deep downturn. The most prominent rate of growth was recorded in 2014 with an increase of 1,213%. As a result, the exports reached the peak of X tons. From 2015 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, medicaments containing insulin exports reduced remarkably to $X in 2021. Over the period under review, exports saw a deep reduction. The pace of growth was the most pronounced in 2014 with an increase of 932%. As a result, the exports reached the peak of $X. From 2015 to 2021, the growth of the exports remained at a lower figure.

Exports by Country

Nigeria (X kg) was the main destination for medicaments containing insulin exports from China, with a 79% share of total exports. Moreover, medicaments containing insulin exports to Nigeria exceeded the volume sent to the second major destination, Sudan (X kg), fourfold.

From 2012 to 2021, the average annual rate of growth in terms of volume to Nigeria totaled -15.8%.

In value terms, Sudan ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from China, comprising 77% of total exports. The second position in the ranking was taken by Nigeria ($X), with a 3.3% share of total exports.

From 2012 to 2021, the average annual growth rate of value to Sudan totaled +14.1%.

Export Prices by Country

In 2021, the average medicaments containing insulin export price amounted to $X per ton, increasing by 21% against the previous year. Over the period under review, export price indicated a temperate increase from 2012 to 2021: its price increased at an average annual rate of +2.1% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing insulin export price increased by +114.5% against 2014 indices. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major foreign markets. In 2021, amid the top suppliers, the country with the highest price was Sudan ($X per ton), while the average price for exports to Nigeria amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Sudan (+2.3%).

Medicaments Containing Insulin Imports

Imports into China

In 2021, purchases abroad of medicaments containing insulin but not antibiotics decreased by -19.6% to X kg, falling for the third consecutive year after three years of growth. Overall, imports faced a sharp curtailment. The most prominent rate of growth was recorded in 2018 when imports increased by 2,127%. Over the period under review, imports attained the peak figure at X tons in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports rose to $X in 2021. In general, imports saw a significant curtailment. The pace of growth was the most pronounced in 2018 with an increase of 747%. Imports peaked at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

Imports by Country

In 2021, the United States (X kg) was the main medicaments containing insulin supplier to China, with a approx. 99% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from the United States amounted to -47.3%.

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to China.

From 2012 to 2021, the average annual rate of growth in terms of value from the United States totaled -54.7%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, jumping by 29% against the previous year. Over the period under review, the import price, however, saw a abrupt decline. The pace of growth appeared the most rapid in 2019 when the average import price increased by 29% against the previous year. Over the period under review, average import prices reached the peak figure at $X per ton in 2014; however, from 2015 to 2021, import prices stood at a somewhat lower figure.

As there is only one major supplying country, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to -13.9% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

Denmark remains the largest medicaments containing insulin consuming country worldwide, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., accounting for 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to China?

In value terms, the U.S. constituted the largest supplier of medicaments containing insulin to China, comprising 82% of total imports. The second position in the ranking was occupied by the Netherlands, with a 18% share of total imports.

What is the average export price for medicaments containing insulin but not antibiotics in China?

The average medicaments containing insulin export price stood at $31,771 per ton in 2020, with an increase of 145% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in China?

In 2020, the average medicaments containing insulin import price amounted to $393,432 per ton, approximately equating the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

China

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in China
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023